Piliguard® Pinkeye+7


Therapeutic Class

Pharmaceutical Name
Clostridium Chauvoei-Septicum-Novyi- Sordellii-Perfringens Types C & D-Moraxella Bovis Bacterin-Toxoid

Features and Benefits
... Stop pinkeye. Stop blackleg. Grow profits.

Aids in the control of pinkeye caused by Moraxella bovis strains expressing pili similar to those expressed by isolates referred to by Merck Animal Health as strains EPP 63, FLA 64, and SAH 38, and against diseases caused by Clostridium chauvoei, C. septicum, C. novyi Type B, C. sordellii and C. perfringens Types C and D. Immunity is also provided against C. perfringens Type B. This immunity is derived from the combination of the Type C (beta) and Type D (epsilon) fractions.

  • Pinkeye/clostridial combination vaccine with proven effectiveness of Advanced Piliation Technology.

  • Cross-reaction with other pilus types.

  • Effective against seven acute and deadly clostridial diseases in combination with Piliguard Pinkeye.

For further information including dose rate and complete directions and warnings, please see the Product Label by clicking here.

Piliguard® Pinkeye+7 is a registered trademark of Intervet Inc.

For more information about products call 1-800-521-5767.

Product Label(s) and MSDS